(en) Essai clinique NCT01659255 intitulé « ONO-4059 Phase I Dose-escalation Study to Investigate the Safety and Tolerability of ONO-4059 Given as Monotherapy in Patients With Relapsed/Refractory Non-Hodgkin's Lymphoma and/or Chronic Lymphocytic Leukaemi » sur ClinicalTrials.gov.
(en) Essai clinique NCT01351935 intitulé « Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia » sur ClinicalTrials.gov.
doi.org
dx.doi.org
Pal Singh S, Dammeijer F, Hendriks RW, « Role of Bruton's tyrosine kinase in B cells and malignancies », Molecular Cancer, vol. 17, no 1, , p. 57 (PMID29455639, DOI10.1186/s12943-018-0779-z)
Montalban X, Arnold DL, Weber MS, Staikov I, Piasecka-Stryczynska K, Willmer J, Martin EC, Dangond F, Syed S, Wolinsky JS, « Placebo-Controlled Trial of an Oral BTK Inhibitor in Multiple Sclerosis », N. Engl. J. Med., vol. 380, no 25, , p. 2406–2417 (PMID31075187, DOI10.1056/NEJMoa1901981)
Nixon JC, Rajaiya JB, Ayers N, Evetts S, Webb CF, « The transcription factor, Bright, is not expressed in all human B lymphocyte subpopulations », Cell. Immunol., vol. 228, no 1, , p. 42–53 (PMID15203319, DOI10.1016/j.cellimm.2004.03.004)
Yasuda T, Tezuka T, Maeda A, Inazu T, Yamanashi Y, Gu H, Kurosaki T, Yamamoto T, « Cbl-b positively regulates Btk-mediated activation of phospholipase C-gamma2 in B cells », J. Exp. Med., vol. 196, no 1, , p. 51–63 (PMID12093870, PMCID2194016, DOI10.1084/jem.20020068)
Hashimoto S, Iwamatsu A, Ishiai M, Okawa K, Yamadori T, Matsushita M, Baba Y, Kishimoto T, Kurosaki T, Tsukada S, « Identification of the SH2 domain binding protein of Bruton's tyrosine kinase as BLNK--functional significance of Btk-SH2 domain in B-cell antigen receptor-coupled calcium signaling », Blood, vol. 94, no 7, , p. 2357–64 (PMID10498607, DOI10.1182/blood.V94.7.2357.419k40_2357_2364)
Vargas L, Nore BF, Berglof A, Heinonen JE, Mattsson PT, Smith CI, Mohamed AJ, « Functional interaction of caveolin-1 with Bruton's tyrosine kinase and Bmx », J. Biol. Chem., vol. 277, no 11, , p. 9351–7 (PMID11751885, DOI10.1074/jbc.M108537200)
Ma YC, Huang XY, « Identification of the binding site for Gqalpha on its effector Bruton's tyrosine kinase », Proc. Natl. Acad. Sci. U.S.A., vol. 95, no 21, , p. 12197–201 (PMID9770463, PMCID22808, DOI10.1073/pnas.95.21.12197)
Sacristán C, Tussié-Luna MI, Logan SM, Roy AL, « Mechanism of Bruton's tyrosine kinase-mediated recruitment and regulation of TFII-I », J. Biol. Chem., vol. 279, no 8, , p. 7147–58 (PMID14623887, DOI10.1074/jbc.M303724200)
Novina CD, Kumar S, Bajpai U, Cheriyath V, Zhang K, Pillai S, Wortis HH, Roy AL, « Regulation of nuclear localization and transcriptional activity of TFII-I by Bruton's tyrosine kinase », Mol. Cell. Biol., vol. 19, no 7, , p. 5014–24 (PMID10373551, PMCID84330, DOI10.1128/mcb.19.7.5014)
Yang W, Desiderio S, « BAP-135, a target for Bruton's tyrosine kinase in response to B cell receptor engagement », Proc. Natl. Acad. Sci. U.S.A., vol. 94, no 2, , p. 604–9 (PMID9012831, PMCID19560, DOI10.1073/pnas.94.2.604)
Guo B, Kato RM, Garcia-Lloret M, Wahl MI, Rawlings DJ, « Engagement of the human pre-B cell receptor generates a lipid raft-dependent calcium signaling complex », Immunity, vol. 13, no 2, , p. 243–53 (PMID10981967, DOI10.1016/s1074-7613(00)00024-8)
Johannes FJ, Hausser A, Storz P, Truckenmüller L, Link G, Kawakami T, Pfizenmaier K, « Bruton's tyrosine kinase (Btk) associates with protein kinase C mu », FEBS Lett., vol. 461, nos 1–2, , p. 68–72 (PMID10561498, DOI10.1016/S0014-5793(99)01424-6)
Matsushita M, Yamadori T, Kato S, Takemoto Y, Inazawa J, Baba Y, Hashimoto S, Sekine S, Arai S, Kunikata T, Kurimoto M, Kishimoto T, Tsukada S, « Identification and characterization of a novel SH3-domain binding protein, Sab, which preferentially associates with Bruton's tyrosine kinase (BtK) », Biochem. Biophys. Res. Commun., vol. 245, no 2, , p. 337–43 (PMID9571151, DOI10.1006/bbrc.1998.8420)
Yamadori T, Baba Y, Matsushita M, Hashimoto S, Kurosaki M, Kurosaki T, Kishimoto T, Tsukada S, « Bruton's tyrosine kinase activity is negatively regulated by Sab, the Btk-SH3 domain-binding protein », Proc. Natl. Acad. Sci. U.S.A., vol. 96, no 11, , p. 6341–6 (PMID10339589, PMCID26883, DOI10.1073/pnas.96.11.6341)
(en) Damian Garde, « Lilly inks a $690M deal to get its hands on an autoimmune drug », FierceBiotech, (lire en ligne)
frontiersin.org
Geier Christoph, « Hypomorphic Mutations in the BCR Signalosome Lead to Selective Immunoglobulin M Deficiency and Impaired B-cell Homeostasis », Frontiers in Immunology, (PMID30619340, lire en ligne)
immunedisease.com
X-Linked Agammaglobulinemia Patient and Family Handbook for The Primary Immune Diseases. Third Edition. 2001. Published by the Immune Deficiency Foundation.
Pal Singh S, Dammeijer F, Hendriks RW, « Role of Bruton's tyrosine kinase in B cells and malignancies », Molecular Cancer, vol. 17, no 1, , p. 57 (PMID29455639, DOI10.1186/s12943-018-0779-z)
Helen Turner et Jean-Pierre Kinet, « Signalling through the high-affinity IgE receptor FcεRI », Nature, vol. 402, no S6760, , p. 24–30 (PMID10586892)
Geier Christoph, « Hypomorphic Mutations in the BCR Signalosome Lead to Selective Immunoglobulin M Deficiency and Impaired B-cell Homeostasis », Frontiers in Immunology, (PMID30619340, lire en ligne)
Montalban X, Arnold DL, Weber MS, Staikov I, Piasecka-Stryczynska K, Willmer J, Martin EC, Dangond F, Syed S, Wolinsky JS, « Placebo-Controlled Trial of an Oral BTK Inhibitor in Multiple Sclerosis », N. Engl. J. Med., vol. 380, no 25, , p. 2406–2417 (PMID31075187, DOI10.1056/NEJMoa1901981)
Nixon JC, Rajaiya JB, Ayers N, Evetts S, Webb CF, « The transcription factor, Bright, is not expressed in all human B lymphocyte subpopulations », Cell. Immunol., vol. 228, no 1, , p. 42–53 (PMID15203319, DOI10.1016/j.cellimm.2004.03.004)
Yasuda T, Tezuka T, Maeda A, Inazu T, Yamanashi Y, Gu H, Kurosaki T, Yamamoto T, « Cbl-b positively regulates Btk-mediated activation of phospholipase C-gamma2 in B cells », J. Exp. Med., vol. 196, no 1, , p. 51–63 (PMID12093870, PMCID2194016, DOI10.1084/jem.20020068)
Hashimoto S, Iwamatsu A, Ishiai M, Okawa K, Yamadori T, Matsushita M, Baba Y, Kishimoto T, Kurosaki T, Tsukada S, « Identification of the SH2 domain binding protein of Bruton's tyrosine kinase as BLNK--functional significance of Btk-SH2 domain in B-cell antigen receptor-coupled calcium signaling », Blood, vol. 94, no 7, , p. 2357–64 (PMID10498607, DOI10.1182/blood.V94.7.2357.419k40_2357_2364)
Vargas L, Nore BF, Berglof A, Heinonen JE, Mattsson PT, Smith CI, Mohamed AJ, « Functional interaction of caveolin-1 with Bruton's tyrosine kinase and Bmx », J. Biol. Chem., vol. 277, no 11, , p. 9351–7 (PMID11751885, DOI10.1074/jbc.M108537200)
Ma YC, Huang XY, « Identification of the binding site for Gqalpha on its effector Bruton's tyrosine kinase », Proc. Natl. Acad. Sci. U.S.A., vol. 95, no 21, , p. 12197–201 (PMID9770463, PMCID22808, DOI10.1073/pnas.95.21.12197)
Sacristán C, Tussié-Luna MI, Logan SM, Roy AL, « Mechanism of Bruton's tyrosine kinase-mediated recruitment and regulation of TFII-I », J. Biol. Chem., vol. 279, no 8, , p. 7147–58 (PMID14623887, DOI10.1074/jbc.M303724200)
Novina CD, Kumar S, Bajpai U, Cheriyath V, Zhang K, Pillai S, Wortis HH, Roy AL, « Regulation of nuclear localization and transcriptional activity of TFII-I by Bruton's tyrosine kinase », Mol. Cell. Biol., vol. 19, no 7, , p. 5014–24 (PMID10373551, PMCID84330, DOI10.1128/mcb.19.7.5014)
Yang W, Desiderio S, « BAP-135, a target for Bruton's tyrosine kinase in response to B cell receptor engagement », Proc. Natl. Acad. Sci. U.S.A., vol. 94, no 2, , p. 604–9 (PMID9012831, PMCID19560, DOI10.1073/pnas.94.2.604)
Guo B, Kato RM, Garcia-Lloret M, Wahl MI, Rawlings DJ, « Engagement of the human pre-B cell receptor generates a lipid raft-dependent calcium signaling complex », Immunity, vol. 13, no 2, , p. 243–53 (PMID10981967, DOI10.1016/s1074-7613(00)00024-8)
Johannes FJ, Hausser A, Storz P, Truckenmüller L, Link G, Kawakami T, Pfizenmaier K, « Bruton's tyrosine kinase (Btk) associates with protein kinase C mu », FEBS Lett., vol. 461, nos 1–2, , p. 68–72 (PMID10561498, DOI10.1016/S0014-5793(99)01424-6)
Matsushita M, Yamadori T, Kato S, Takemoto Y, Inazawa J, Baba Y, Hashimoto S, Sekine S, Arai S, Kunikata T, Kurimoto M, Kishimoto T, Tsukada S, « Identification and characterization of a novel SH3-domain binding protein, Sab, which preferentially associates with Bruton's tyrosine kinase (BtK) », Biochem. Biophys. Res. Commun., vol. 245, no 2, , p. 337–43 (PMID9571151, DOI10.1006/bbrc.1998.8420)
Yamadori T, Baba Y, Matsushita M, Hashimoto S, Kurosaki M, Kurosaki T, Kishimoto T, Tsukada S, « Bruton's tyrosine kinase activity is negatively regulated by Sab, the Btk-SH3 domain-binding protein », Proc. Natl. Acad. Sci. U.S.A., vol. 96, no 11, , p. 6341–6 (PMID10339589, PMCID26883, DOI10.1073/pnas.96.11.6341)